Last 7 days
-0.7%
Last 30 days
-4.5%
Last 90 days
-9.2%
Trailing 12 Months
-14.3%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-24 | Powell Ann | sold | -1,101,640 | 61.25 | -17,986 | evp, chief human resources |
2023-08-03 | Plenge Robert M | sold | -44,754 | 61.14 | -732 | evp, chief research officer |
2023-07-01 | Weese Michelle | acquired | - | - | 1,885 | evp, corporate affairs |
2023-07-01 | Hirawat Samit | sold (taxes) | -306,129 | 63.95 | -4,787 | evp,chief med.offr.,drug dev. |
2023-07-01 | Hirawat Samit | acquired | - | - | 9,357 | evp,chief med.offr.,drug dev. |
2023-07-01 | Weese Michelle | sold (taxes) | -43,613 | 63.95 | -682 | evp, corporate affairs |
2023-06-03 | Lenkowsky Adam | sold (taxes) | -36,178 | 65.66 | -551 | evp, chief commercial officer |
2023-06-03 | Lenkowsky Adam | acquired | - | - | 1,077 | evp, chief commercial officer |
2023-05-03 | VESSEY RUPERT | sold | -3,378,820 | 67.06 | -50,385 | evp & president, research |
2023-05-02 | Greenlees Sharon | acquired | - | - | 1,017 | svp & controller |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-19 | BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL | added | 0.35 | -228,812 | 2,858,120 | 1.20% |
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | unchanged | - | -27,872 | 332,540 | 0.28% |
2023-09-14 | IMS Capital Management | added | 0.25 | -31,184 | 384,929 | 0.21% |
2023-09-14 | Proquility Private Wealth Partners, LLC | added | 0.16 | -97,698 | 1,190,360 | 0.47% |
2023-09-12 | DCM Advisors, LLC | sold off | -100 | -213,891 | - | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 325 | 936,805 | 1,256,810 | 0.28% |
2023-09-11 | Dechtman Wealth Management, LLC | new | - | 640,987 | 640,987 | 0.19% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | reduced | -6.8 | -1,000 | 6,139 | -% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 1,456,140 | 1,456,140 | 0.08% |
2023-09-07 | JAG CAPITAL MANAGEMENT, LLC | reduced | -16.66 | -74,653 | 248,580 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.54% | 202,927,620 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 8.1% | 172,720,377 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.00% | 199,834,483 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.6% | 169,226,706 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.82% | 199,340,458 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.6% | 172,464,804 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 8.32% | 194,860,154 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 7.3% | 171,343,446 | SC 13G/A | |
Jan 28, 2020 | wellington management group llp | 3.57% | 83,470,877 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 28, 2023 | 4 | Insider Trading | |
Aug 24, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 10, 2023 | 8-K | Current Report | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 144 | Notice of Insider Sale Intent | |
Jul 27, 2023 | 10-Q | Quarterly Report | |
Jul 27, 2023 | 8-K | Current Report | |
Jul 05, 2023 | 4 | Insider Trading | |
Jul 05, 2023 | 3 | Insider Trading | |
Jul 05, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 495.0B | 29.5B | -0.64% | 86.07% | 76.18 | 16.77 | 1.53% | 14.16% |
JNJ | 420.1B | 97.8B | -2.63% | 0.36% | 32.18 | 4.3 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -0.47% | 27.98% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 185.5B | 77.9B | -10.83% | -24.56% | 8.64 | 2.38 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -4.49% | -14.30% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.73% | 596.48% | -74.02 | 4.1K | -86.94% | 71.24% |
PRGO | 4.4B | 4.6B | -13.48% | -15.45% | -65.31 | 0.95 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
TLRY | 1.6B | 627.1M | -7.75% | -19.97% | -1.08 | 2.5 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -13.44% | -19.42% | 34.58 | 2.36 | 0.62% | -24.59% |
INVA | 843.4M | 244.3M | -2.42% | 7.48% | 4.28 | 3.45 | -39.50% | -4.99% |
CRON | 807.9M | 109.5M | 20.45% | -29.10% | -5.63 | 7.38 | -2.66% | -32.13% |
ACRS | 482.6M | 31.2M | -9.55% | -49.48% | -4.58 | 15.49 | 407.54% | -26.47% |
CGC | 422.3M | 453.3M | 90.89% | -73.90% | -0.34 | 0.93 | -16.04% | 55.90% |
OCUL | 258.3M | 54.6M | -16.41% | -43.89% | -2.85 | 4.73 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
5.1%
3.4%
1.6%
3.1%
45%
1.9%
0%
Y-axis is the maximum loss one would have experienced if Bristol-Myers Squibb was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -1.4% | 45,187 | 45,848 | 46,159 | 46,738 | 47,144 | 46,960 | 46,385 | 45,468 | 44,384 | 42,810 | 42,518 | 39,395 | 34,862 | 31,006 | 26,145 | 24,173 | 23,857 | 23,288 | 22,561 | 22,037 | 21,600 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | 30,745 | 28,040 | 24,219 | 21,090 | 18,067 | 16,819 | 16,794 | 16,384 | - | - | - |
Costs and Expenses | -1.5% | 36,490 | 37,052 | 38,446 | 39,026 | 39,484 | 39,705 | 38,287 | 49,679 | 48,495 | 46,847 | 49,389 | 35,944 | 32,319 | 28,314 | 21,170 | 17,564 | 16,430 | 17,120 | 16,593 | 16,876 | 17,423 |
S&GA Expenses | 1.9% | 7,892 | 7,745 | 7,814 | 7,902 | 7,760 | 7,855 | 7,690 | 8,057 | 7,975 | 7,721 | 7,661 | 6,674 | 6,023 | 5,471 | 4,871 | 4,473 | 4,522 | 4,577 | 4,551 | 4,531 | 4,590 |
R&D Expenses | -0.7% | 9,507 | 9,570 | 9,509 | 9,517 | 10,079 | 10,236 | 10,195 | 10,332 | 9,851 | 9,895 | 10,048 | 9,490 | 8,369 | 7,172 | 6,148 | 5,418 | 5,320 | 6,430 | 6,332 | 6,890 | 7,171 |
EBITDA | -100.0% | - | 18,917 | 17,989 | 19,446 | 19,546 | 19,355 | 20,284 | 8,200 | 8,228 | 8,134 | 5,109 | 12,791 | 9,399 | 7,159 | 7,135 | 7,491 | 8,303 | 7,032 | 6,805 | 6,023 | 5,062 |
EBITDA Margin | -100.0% | - | 0.41* | 0.39* | 0.42* | 0.42* | 0.41* | 0.44* | 0.18* | 0.19* | 0.19* | 0.12* | 0.32* | 0.27* | 0.23* | 0.27* | 0.31* | 0.35* | 0.30* | 0.30* | 0.27* | 0.23* |
Earnings Before Taxes | -1.1% | 8,697 | 8,796 | 7,713 | 7,712 | 7,660 | 7,255 | 8,098 | -4,211 | -4,111 | -4,037 | -6,871 | 3,451 | 2,543 | 2,692 | 4,975 | 6,609 | 7,427 | 6,168 | 5,968 | 5,161 | 4,177 |
EBT Margin | -100.0% | - | 0.19* | 0.17* | 0.17* | 0.16* | 0.15* | 0.17* | -0.09* | -0.09* | -0.09* | -0.16* | 0.09* | 0.07* | 0.09* | 0.19* | 0.27* | 0.31* | 0.26* | 0.26* | 0.23* | 0.19* |
Net Income | 8.9% | 7,963 | 7,311 | 6,327 | 6,677 | 6,617 | 6,251 | 6,994 | -5,405 | -5,079 | -6,219 | -9,015 | -44.00 | -563 | 954 | 3,439 | 5,655 | 6,203 | 5,144 | 4,920 | 1,432 | 376 |
Net Income Margin | -100.0% | - | 0.16* | 0.14* | 0.14* | 0.14* | 0.13* | 0.15* | -0.12* | -0.11* | -0.15* | -0.21* | 0.00* | -0.02* | 0.03* | 0.13* | 0.23* | 0.26* | 0.22* | 0.22* | 0.06* | 0.02* |
Free Cashflow | -100.0% | - | 11,081 | 11,948 | 12,725 | 14,281 | 15,142 | 15,234 | 14,884 | 11,687 | 13,242 | 13,299 | 11,842 | 12,409 | 9,896 | 7,374 | 7,583 | 6,272 | 5,239 | 4,989 | 3,713 | 4,109 |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -0.8% | 93,489 | 94,281 | 96,820 | 98,196 | 100,357 | 103,034 | 109,314 | 110,893 | 110,797 | 112,435 | 118,481 | 125,536 | 128,076 | 129,285 | 129,944 | 57,433 | 55,163 | 34,834 | 34,986 | 33,734 | 32,641 |
Current Assets | 3.6% | 28,074 | 27,086 | 27,273 | 26,796 | 30,186 | 30,121 | 33,262 | 31,443 | 29,161 | 27,111 | 30,192 | 34,277 | 34,343 | 31,853 | 29,354 | 40,191 | 37,716 | 17,093 | 17,716 | 14,869 | 13,874 |
Cash Equivalents | -6.9% | 8,372 | 8,995 | 9,123 | 7,734 | 10,960 | 12,579 | 14,316 | 13,879 | 11,397 | 11,321 | 14,973 | 19,860 | 20,362 | 16,246 | 12,820 | 30,489 | 28,404 | 7,335 | 6,911 | 5,408 | 4,999 |
Inventory | -9.3% | 2,364 | 2,605 | 2,339 | 2,074 | 2,142 | 2,104 | 2,095 | 2,163 | 2,137 | 1,953 | 2,074 | 1,949 | 2,384 | 2,836 | 4,293 | 1,192 | 1,308 | 1,283 | 1,195 | 1,282 | 1,242 |
Net PPE | 1.2% | 6,355 | 6,279 | 6,255 | 6,035 | 5,970 | 6,047 | 6,049 | 5,868 | 5,795 | 5,763 | 5,886 | 5,740 | 5,777 | 6,112 | 6,252 | 4,830 | 4,849 | 4,985 | 5,027 | 5,092 | 5,080 |
Goodwill | 0.0% | 21,163 | 21,162 | 21,149 | 21,112 | 20,446 | 20,500 | 20,502 | 20,519 | 20,529 | 20,524 | 20,547 | 20,517 | 20,578 | 22,452 | 22,488 | 6,513 | 6,533 | 6,536 | 6,538 | 6,686 | 6,683 |
Liabilities | -1.5% | 61,459 | 62,395 | 65,702 | 65,462 | 67,696 | 71,389 | 73,308 | 73,609 | 73,923 | 74,762 | 80,599 | 75,306 | 78,916 | 79,308 | 78,246 | 39,679 | 39,012 | 19,517 | 20,859 | 19,984 | 20,223 |
Current Liabilities | 5.6% | 20,150 | 19,085 | 21,890 | 18,930 | 20,915 | 22,821 | 21,868 | 21,460 | 18,991 | 17,330 | 19,080 | 20,464 | 23,421 | 19,232 | 18,304 | 10,489 | 9,711 | 8,841 | 10,654 | 9,694 | 9,878 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 50,336 | 44,614 | 46,106 | 46,105 | 46,150 | 24,390 | 24,433 | 5,635 | - | - | - |
LT Debt, Non Current | -1.2% | 34,656 | 35,078 | 35,056 | 36,966 | 37,107 | 37,450 | 39,605 | 39,677 | 42,503 | 44,505 | 48,336 | 41,364 | 41,853 | 42,844 | 43,387 | 24,390 | 24,433 | 5,635 | 5,646 | 5,687 | 5,671 |
Shareholder's Equity | 0.5% | 31,973 | 31,824 | 31,061 | 32,671 | 32,600 | 31,580 | 35,946 | 37,213 | 36,808 | 37,605 | 37,822 | 50,230 | 49,160 | 49,977 | 51,598 | 17,754 | 16,151 | 15,317 | 14,031 | 13,750 | 12,418 |
Retained Earnings | 3.3% | 27,449 | 26,568 | 25,503 | 24,675 | 24,217 | 23,948 | 23,820 | 22,625 | 22,168 | 22,204 | 21,281 | 32,414 | 31,565 | 32,671 | 34,474 | 36,555 | 35,870 | 35,109 | 34,065 | 33,292 | 32,044 |
Additional Paid-In Capital | 0.4% | 45,299 | 45,140 | 45,165 | 44,956 | 44,375 | 43,756 | 44,361 | 44,292 | 44,064 | 43,852 | 44,325 | 44,435 | 44,444 | 43,254 | 43,709 | 2,206 | 2,150 | 2,103 | 2,081 | 2,029 | 1,966 |
Minority Interest | -8.1% | 57.00 | 62.00 | 57.00 | 63.00 | 61.00 | 65.00 | 60.00 | 71.00 | 66.00 | 68.00 | 60.00 | 72.00 | 66.00 | 66.00 | 100 | 106 | 102 | 99.00 | 96.00 | 110 | 101 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -3.1% | 11,850 | 12,224 | 13,066 | 13,817 | 15,396 | 16,195 | 16,207 | 15,505 | 12,506 | 13,939 | 14,052 | 12,878 | 13,167 | 10,757 | 8,210 | 9,584 | 8,307 | 7,281 | 7,066 | 4,628 | 5,062 |
Share Based Compensation | 4.4% | 493 | 472 | 457 | 471 | 498 | 539 | 583 | 621 | 664 | 720 | 779 | 892 | 763 | 598 | 441 | 210 | 216 | 219 | 221 | 218 | 206 |
Cashflow From Investing | -2.9% | -1,407 | -1,367 | -1,062 | -1,874 | -769 | -300 | -538 | -12,751 | -11,988 | -11,612 | -10,859 | -11,226 | -10,522 | -10,363 | -9,913 | 804 | 166 | -897 | -2,000 | 481 | 770 |
Cashflow From Financing | 9.4% | -13,012 | -14,359 | -16,962 | -17,683 | -14,920 | -14,582 | -16,224 | -8,774 | -9,581 | -7,392 | -1,151 | -12,311 | -10,665 | 8,596 | 7,621 | 14,720 | 14,941 | -4,342 | -3,535 | -4,309 | -4,295 |
Dividend Payments | 1.0% | 4,692 | 4,645 | 4,634 | 4,588 | 4,524 | 4,473 | 4,396 | 4,318 | 4,244 | 4,166 | 4,075 | 3,722 | 3,377 | 3,027 | 2,679 | 2,664 | 2,646 | 2,629 | 2,613 | 2,599 | 2,586 |
Buy Backs | 26.9% | 4,272 | 3,367 | 8,001 | 8,452 | 8,276 | 9,512 | 6,287 | 5,001 | 4,476 | 3,240 | 1,546 | 7,081 | 7,381 | 7,381 | 7,300 | 300 | - | 153 | 320 | 569 | 789 |
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |||
Total revenues | $ 11,226 | $ 11,887 | $ 22,563 | $ 23,535 | ||
Cost of products sold | [1] | 2,876 | 2,720 | 5,442 | 5,191 | |
Marketing, selling and administrative | 1,934 | 1,787 | 3,696 | 3,618 | ||
Research and development | 2,258 | 2,321 | 4,579 | 4,581 | ||
Acquired IPRD | 158 | 400 | 233 | 733 | ||
Amortization of acquired intangible assets | 2,257 | 2,417 | 4,513 | 4,834 | ||
Other (income)/expense, net | (116) | 284 | (529) | 933 | ||
Total Expenses | 9,367 | 9,929 | 17,934 | 19,890 | ||
Earnings before income taxes | 1,859 | 1,958 | 4,629 | 3,645 | ||
Income tax (benefit)/provision | (218) | 529 | 285 | 933 | ||
Net earnings | 2,077 | 1,429 | 4,344 | 2,712 | ||
Noncontrolling interest | 4 | 8 | 9 | 13 | ||
Net earnings attributable to BMS | $ 2,073 | $ 1,421 | $ 4,335 | $ 2,699 | ||
Earnings per common share: | ||||||
Basic (usd per share) | $ 0.99 | $ 0.67 | $ 2.07 | $ 1.26 | ||
Diluted (usd per share) | $ 0.99 | $ 0.66 | $ 2.06 | $ 1.25 | ||
Net product sales | ||||||
Total revenues | $ 10,917 | $ 11,485 | $ 21,965 | $ 22,793 | ||
Alliance and other revenues | ||||||
Total revenues | $ 309 | $ 402 | $ 598 | $ 742 | ||
|
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 8,372 | $ 9,123 |
Marketable debt securities | 358 | 130 |
Receivables | 10,112 | 9,886 |
Inventories | 2,364 | 2,339 |
Other current assets | 6,868 | 5,795 |
Total Current assets | 28,074 | 27,273 |
Property, plant and equipment | 6,355 | 6,255 |
Goodwill | 21,163 | 21,149 |
Other intangible assets | 31,303 | 35,859 |
Deferred income taxes | 1,572 | 1,344 |
Other non-current assets | 5,022 | 4,940 |
Total Assets | 93,489 | 96,820 |
Current liabilities: | ||
Short-term debt obligations | 3,020 | 4,264 |
Accounts payable | 3,069 | 3,040 |
Other current liabilities | 14,061 | 14,586 |
Total Current liabilities | 20,150 | 21,890 |
Deferred income taxes | 751 | 2,166 |
Long-term debt | 34,656 | 35,056 |
Other non-current liabilities | 5,902 | 6,590 |
Total Liabilities | 61,459 | 65,702 |
Commitments and Contingencies | ||
BMS Shareholders’ equity: | ||
Preferred stock | 0 | 0 |
Common stock | 292 | 292 |
Capital in excess of par value of stock | 45,299 | 45,165 |
Accumulated other comprehensive loss | (1,387) | (1,281) |
Retained earnings | 27,449 | 25,503 |
Less cost of treasury stock | (39,680) | (38,618) |
Total BMS Shareholders’ equity | 31,973 | 31,061 |
Noncontrolling interest | 57 | 57 |
Total Equity | 32,030 | 31,118 |
Total Liabilities and Equity | $ 93,489 | $ 96,820 |